Mice lacking substance P have normal bone modeling but diminished bone formation, increased resorption, and accelerated osteopenia with aging

• Published in: Bone (New York, N.Y.) Vol. 144; p. 115806
• Main Authors: Wang, Liping, Hou, Saiyun, Sabsovich, Ilya, Guo, Tian-Zhi, Wei, Tzuping, Kingery, Wade S.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.03.2021
• Subjects: Aging; Animals; Bone; Bone and Bones; Bone Diseases, Metabolic - genetics; Bone remodeling; Bone Resorption - genetics; Mice; Osteogenesis; Osteopenia; Substance P; Substance P - genetics; RANKL; N.Oc/BS; Tb.N; Bone remodeling; BMMs; Ct. BV/TV; Tb.Sp; BFR/BS; BV/TV; Tt.A; NK1; BMD; Aging; ConnD; Me. BV/TV; SP; Osteopenia; B.Ar; B.P; Substance P; B.Ar/T.Ar; CRLR; Me.Ar; Ct.Th; Tb.Th; DPD; Bone; CGRP; RAMP1; BMSCs
• ISSN: 8756-3282; 1873-2763; 1873-2763
• DOI: 10.1016/j.bone.2020.115806

Substance P (SP) is a sensory neuropeptide that is expressed by the neurons innervating bone. There is considerable evidence that SP can regulate bone cell function in vitro, but it is unclear whether SP modulates bone modeling or remodeling in vivo. To answer this question we characterized the bone phenotype of mice with deletion of the Tac1 gene expressing SP. The phenotypes of 2-month-old and 5-month-old SP deficient mice and their wildtype controls were characterized by using μCT imaging, static and dynamic bone histomorphometry, and urinary deoxypyridinoline cross-links (DPD) measurement. No differences in bone phenotypes were observed between the 2 strains at 2 months of age. By 5 months both the wildtype and SP deficient mice had developed cancellous osteopenia, but relative to the wild-type mice the SP deficient mice had significantly greater cancellous bone loss. The SP deficient mice also exhibited decreased bone formation, increased osteoclast number, and increased urinary DPD levels. Cortical defect early repair was delayed in 5-month-old mice lacking SP. Collectively, these findings indicate that SP signaling is not required for bone modeling, but SP signaling reduces age-related osteopenia and accelerates cortical defect reparation, data supporting the hypothesis that SP is an anabolic physiologic regulator of bone metabolism.